Daria Abolghasemi, DO
Surgical Oncology · Baltimore, MDNPI 1265847636
Payments from drug & device makers
What this record shows
Axogen accounts for 69.0% of it on its own, with 9 other manufacturers making up the rest.
Across 19 payments — averaging $118.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$2K
- Stryker$158
- Genentech USA, Inc.$133
- Kerecis Limited$122
- Merck$122
- Dilon Technologies, Inc.$59
- plus $103 from 4 others
What the payments were for
- Travel & lodging$98144%
- Food & beverage$1,26656%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 6 | $1,550 |
| Stryker | 3 | $158 |
| Genentech USA, Inc. | 1 | $133 |
| Kerecis Limited | 1 | $122 |
| Merck | 3 | $122 |
| Dilon Technologies, Inc. | 1 | $59 |
| Hologic Sales And Service, LLC | 1 | $34 |
| Impedimed, Inc. | 1 | $34 |
| Avanos Medical | 1 | $19 |
| Geron Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AXOGUARD$2,813
- AXOGUARD HA+ NERVE PROTECTOR$1,406
- AxoGuard Nerve Cap$1,406
- Kerecis SurgiClose$488
- Herceptin$133
- Perjeta$133
- Kadcyla$133
- Kerecis GraftGuide$122
How this compares
$2,247 in reported general payments places this provider in the 75th percentile of 40 surgical oncology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Baltimore
- Kerri LopezBaltimore$16K
- Rebecca BrownBaltimore$13K
- Arun MavanurBaltimore$4K
- Armando SardiBaltimore$2K
- Lisa JacobsBaltimore$2K
- Richelle WilliamsBaltimore$2K
- Humair QuadriBaltimore$1K
- Kelly LafaroBaltimore$945
- Ray Gervacio BlancoBaltimore$502
- Jeremy DavisBaltimore$376
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.